ElectroHeal

(An Injectable Electrically Conductive Gelatin–Alginate–AuNP Hydrogel for Myocardial Regeneration)
Myocardial infarction (MI), commonly known as a heart attack, leads to irreversible loss of cardiomyocytes and formation of scar tissue that disrupts the heart’s electrical conductivity and contractility. Traditional therapies only manage symptoms but fail to restore native tissue architecture and function. Tissue engineering approaches using electrically conductive hydrogels offer a promising solution by providing both structural support and electrical signaling to reestablish synchronized myocardial contraction.

Contact

Dr. Hossein Ahmadi Tafti

Professor of Cardiac Surgery

This study presents ElectroHeal, an injectable hydrogel composed of gelatin, alginate, and gold nanoparticles (AuNPs)—engineered to mimic the native cardiac microenvironment and support the growth and function of mouse embryonic cardiac cells (mECCs).

 

ElectroHeal Composition and Characteristics

Scaffold: Gelatin / Alginate / Gold Nanoparticles (AuNPs)

Drug/Growth Factor: None

Cells: Mouse Embryonic Cardiac Cells (mECCs)

Key Features:
• Injectable formulation for minimally invasive delivery
• Electrically conductive due to uniform dispersion of AuNPs
• Promotes electrical coupling between cardiac cells
• Excellent biocompatibility and cell adhesion
• Tailored gelation time and mechanical integrity suitable for cardiac tissue

Figure 1

In Vivo Evaluation
Animal Model:
Rat model of surgically induced MI Procedure:
Outcome:
• Improved electrical conductivity and tissue integration
• Enhanced mECC survival and alignment
• Reduction in fibrotic area and improvement in left ventricular function
• No significant inflammatory response observed

Figure 2